Mahipal Singh Sankhla
Unknown Affiliation

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

Emergence of Synthetic Cannabinoids as Drugs of Abuse Nupur Joshi; Mahipal Singh Sankhla
Indian Journal of Forensic Medicine & Toxicology Vol. 16 No. 1 (2022): Indian Journal of Forensic Medicine & Toxicology
Publisher : Institute of Medico-legal Publications Pvt Ltd

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37506/ijfmt.v16i1.17422

Abstract

Cannabis has been the most commonly used drug throughout the world for centuries. The psychoactiveproperties of cannabis are largely attributed to Δ9-tetrahydrocannabinol or THC, the active psychoactiveingredient in the cannabis plant. Lately, new psychoactive substances (NPS) have appeared that aremostly ruled by cathinone’s and synthetic cannabinoids (SCs). SC’s have emerged as drugs of abusebecause of their ability to mimic the euphoric effects of THC. Sprayed on natural herb mixtures, theywere initially sold as ‘herbal incense’ or ‘herbal smoking blends’ as substitutes for cannabis. Thesesynthetic drugs became popular as ‘legal highs’ under brand names such as Spice, K2, Mojo and manyothers in the early 2000’s. SC’s stimulate the same CB1 and CB2 receptors as THC but they are linkedto higher toxicity in terms of duration and severity than cannabis. This is because SC’s act as directagonist of cannabinoid receptors, whereas THC being a partial agonist. Reports suggest that SC’s areassociated with a range of undesired pulmonary, cardiovascular, gastrointestinal effects. Long term SCuse is also linked to severe cognitive deficits. With the global rise in use of SC products, it is importantto develop and validate the screening procedures and investigate the toxicological and pharmacologicalaspects and risk factors associated with its use and abuse.